跳至主要内容
临床试验/EUCTR2019-004297-26-EE
EUCTR2019-004297-26-EE进行中(未招募)1 期

Prophylactic treatment of the ductus arteriosus in preterm infants by acetaminophen - TREOCAPA

Institut National de la Santé et de la Recherche Médicale (INSERM)0 个研究点目标入组 824 人开始时间: 2020年5月28日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
824

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • ? Birth between 23-26 W for Phase II, between 23-28 W for Phase III
  • ? Post natal age < 12 hours
  • ? Parental or Legal Authority Consent
  • ? Parents with a social security or health insurance (if applicable)
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 824
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • ? Birth defect / Congenital anomaly
  • ? Twin-to-twin transfusion syndrome
  • ? Suspicion of pulmonary hypoplasia
  • ?Suspicion of hepatic impairment (hemorrhagic syndrome and/or severe hypoglycemia)
  • ? Clinical instability that can lead to rapid death
  • ? Impossibility to start treatment before 12 hours of life
  • ? Parents placed under judicial protection
  • ? Participation in other clinical trial using acetaminophen during the first 5 days of life, indomethacin or ibuprofen during the first 3 days of life or using rescue treatment of PDA not recommended in the TREOCAPA trial

研究者

发起方
Institut National de la Santé et de la Recherche Médicale (INSERM)

相似试验

Prophylactic treatment of the ductus arteriosus in... | 临床试验